Merck (MSD)

Merck & Co., Inc., known as MSD (Merck Sharp & Dohme) outside the U.S. and Canada, is a global biopharmaceutical company founded in 1891. The company is renowned for developing medicines, vaccines, biologic therapies, and animal health products. Merck is especially recognized for its breakthroughs in oncology, vaccines, infectious diseases, and cardiovascular health.

Mission and Vision

Mission: To save and improve lives around the world with innovative medicines and vaccines.
Vision: To be the premier research-intensive biopharmaceutical company dedicated to advancing science for the health of humanity.

Products and Services

Oncology: Flagship cancer treatment Keytruda (immuno-oncology therapy).
Vaccines: Human papillomavirus (HPV) vaccine Gardasil, and other vaccines for diseases like hepatitis, measles, and pneumococcal infections.
Infectious Diseases: Treatments for HIV, hepatitis C, and antibacterial therapies.
Cardiovascular & Metabolic Health: Medicines for diabetes, hypertension, and cholesterol management.
Animal Health: Veterinary vaccines, medicines, and services for livestock and pets.

Growth and Innovation
Merck has heavily invested in oncology research, with Keytruda becoming one of the most important cancer therapies globally. The company is also a leader in vaccine development, particularly with its HPV vaccine that has had a profound impact on reducing cervical cancer risks. Merck continues to innovate in biologics, antiviral therapies, and digital health initiatives.

Global Impact
Operating in more than 140 countries, Merck has a significant footprint in global health. Its medicines and vaccines reach hundreds of millions annually, and the company collaborates with governments, NGOs, and research institutions to expand access. Merck also prioritizes global health equity, contributing to programs for neglected diseases and underserved communities.